PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2021 April; 12(2): e0010. ISSN: 2076-9172Published online 2021 April 29. doi: 10.5041/RMMJ.10433

Table 3.

MIS-C National Clinical Trials (NCT) Listed in PubMed.

#	NCT No.	Abbreviated Study Description	Age	Patients, n	Status
1	04456439	Intermediate-size EAP (MSC) for MIS-C associated with COVID-19	2mo–17y	~50	Available
2	04588363	OS in COVID-19 infections and MIS-C	<20y	250	Recruiting
3	04538495	OS: characterization of MIS-C and its relationship to Kawasaki Disease	>1mo	100	Recruiting
4	04640038	Contrast-enhanced ultrasound in COVID-19	<17y	30	Recruiting
5	04659486	Adolescents with COVID-19/MIS-C at HCFMUSP	7–18y	100	Enrolling by invitation
6	04549285	MSC infusions in children with MIS-C	18–20y	6	Not yet recruiting

EAP, expanded access program; HCFMUSP, Hospital das Clínicas da Faculdade de Medicina da USP, Sao Paolo, Brazil; mo, month; MIS-C, multisystem inflammatory syndrome in children; MSC, mesenchymal stromal cells; OS, observational study; y, year.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2021 April; 12(2): e0010. ISSN: 2076-9172

Published online 2021 April 29. doi: 10.5041/RMMJ.10433